recall
saveSpecGx, LLC recall (Cls II)
January 14, 2026updated 5mo ago
community read0 votes
Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493 — Reason: Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets. — Status: Ongoing
view source ↗Data sources
last refreshed 31m ago
Found something off?
same company · ±60 days · 6
- recallSpecGx, LLC recall (Cls II)Jan 14, 2026
- approvaltramadol hydrochloride ER: TRAMADOL HYDROCHLORIDE — FDA approvalDec 31, 2025
- approvalacetaminophen ER: OXYCET (ACETAMINOPHEN) — FDA approvalDec 29, 2025
- approvalacetaminophen ER: OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 29, 2025
- approvalMETHADONE HYDROCHLORIDE: METHADOSE (METHADONE HYDROCHLORIDE) — FDA approvalDec 23, 2025
- approvalPRUCALOPRIDE SUCCINATE — FDA approvalFeb 5, 2026
🐶 often sniffed alongside
top 8- tagApproval500 co-mentions · 250 sources
- tagSmall Molecule209 co-mentions · 209 sources
- drugHYDROCODONE BITARTRATE AND ACETAMINOPHEN144 co-mentions · 84 sources
- drugMETHADOSE136 co-mentions · 86 sources
- drugMETHADONE HYDROCHLORIDE86 co-mentions · 86 sources
- drugmethadone hydrochloride ODT86 co-mentions · 86 sources
- drugfentanyl46 co-mentions · 23 sources
- drugFENTANYL-3746 co-mentions · 23 sources
comments(0)
5-min edit window · permanent after that